drugset / Trial / NCT06426537

Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches

NCT06426537

Phase 0 Completed 63 enrolled University of Brawijaya
RandomizedParallel-groupSingle-blindSupportive care

Summary

This study investigates the effect of Colchicine in preventing heart structure changes following ST-segment elevation myocardial infarction. Through a clinical trial involving patients requiring coronary intervention, we explore how Colchicine can reduce inflammation and fibrosis, two crucial factors influencing heart failure post-heart attack. The outcomes are expected to offer new insights into post-heart attack treatments to prevent heart failure.

Timeline

Start
2022-10-20
Primary completion
2023-03-25
Completion
2023-11-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colchicine Small molecule 0.5 mg Oral